The successful use of pamidronate in an 11-year-old girl with complex regional pain syndrome: Response to treatment demonstrated by serial peripheral quantitative computerised tomographic scans

Bone

Volumn 46, Issue 4, 2010, Pages 885-888

  Simm, P J ^a   Briody, J ^a   McQuade, M ^a   Munns, C F ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Bisphosphonates; Complex regional pain syndrome; Pamidronate; Peripheral quantitative computerised tomography; Reflex sympathetic dystrophy

Indexed keywords

PAMIDRONIC ACID;

ABSENCE OF SIDE EFFECTS; ARTICLE; BONE DENSITY; BONE MASS; CASE REPORT; CHILD; COMPARTMENT SYNDROME; COMPLEX REGIONAL PAIN SYNDROME; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FUNCTIONAL STATUS; HUMAN; MUSCLE ATROPHY; OSTEOPENIA; PHYSIOTHERAPY; SCHOOL CHILD; SYMPATHETIC BLOCKING; TIBIA FRACTURE;

ABSORPTIOMETRY, PHOTON; ANTI-INFLAMMATORY AGENTS; BONE DENSITY; CHILD; DIPHOSPHONATES; FEMALE; HUMANS; LEG; REFLEX SYMPATHETIC DYSTROPHY; TIBIA; TIBIAL FRACTURES; TREATMENT OUTCOME;

EID: 77950529118     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.11.034     Document Type: Article

References (31)

1. Tan E.C., Zijlstra B., Essink M.L., Goris R.J., Severijnen R.S. Complex regional pain syndrome type I in children. Acta Paediatr. 2008, 97:875-879.
2. Schinkel C., Scherens A., Koller M., Roellecke G., Muhr G., Maier C. Systemic inflammatory mediators in post-traumatic complex regional pain syndrome (CRPS I)-longitudinal investigations and differences to control groups. Eur. J. Med. Res. 2009, 14:130-135.
3. Albazaz R., Wong Y.T., Homer-Vanniasinkam S. Complex regional pain syndrome: a review. Ann. Vasc. Surg. 2008, 22:297-306.
4. Sherry D.D., Wallace C.A., Kelley C., Kidder M., Sapp L. Short- and long-term outcomes of children with complex regional pain syndrome type I treated with exercise therapy. Clin. J. Pain 1999, 15:218-223.
5. Cepeda M.S., Carr D.B., Lau J. Local anesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst. Rev. 2005, CD004598.
6. Murray C.S., Cohen A., Perkins T., Davidson J.E., Sills J.A. Morbidity in reflex sympathetic dystrophy. Arch. Dis. Child. 2000, 82:231-233.
7. Brunner F., Schmid A., Kissling R., Held U., Bachmann L.M. Biphosphonates for the therapy of complex regional pain syndrome I-systematic review. Eur. J. Pain 2009, 13:17-21.
8. Cortet B., Flipo R.M., Coquerelle P., Duquesnoy B., Delcambre B. Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate. Clin. Rheumatol. 1997, 16:51-56.
9. Kubalek I., Fain O., Paries J., Kettaneh A., Thomas M. Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases. Rheumatology (Oxford) 2001, 40:1394-1397.
10. Siu W.S., Qin L., Leung K.S. pQCT bone strength index may serve as a better predictor than bone mineral density for long bone breaking strength. J. Bone Miner. Metab. 2003, 21:316-322.
11. Felin E.M., Prahalad S., Askew E.W., Moyer-Mileur L.J. Musculoskeletal abnormalities of the tibia in juvenile rheumatoid arthritis. Arthritis Rheum. 2007, 56:984-994.
12. Lu P.W., Briody J.N., Ogle G.D., Morley K., Humphries I.R., Allen J., et al. Bone mineral density of total body, spine, and femoral neck in children and young adults: a cross-sectional and longitudinal study. J. Bone Miner. Res. 1994, 9:1451-1458.
13. Hicks C.L., von Baeyer C.L., Spafford P.A., van Korlaar I., Goodenough B. The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain 2001, 93:173-183.
14. Adami S., Fossaluzza V., Gatti D., Fracassi E., Braga V. Bisphosphonate therapy of reflex sympathetic dystrophy syndrome. Ann. Rheum. Dis. 1997, 56:201-204.
15. Robinson J.N., Sandom J., Chapman P.T. Efficacy of pamidronate in complex regional pain syndrome type I. Pain Med. 2004, 5:276-280.
16. Munns C.F., Rauch F., Travers R., Glorieux F.H. Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome. J. Bone Miner. Res. 2005, 20:1235-1243.
17. Montpetit K., Plotkin H., Rauch F., Bilodeau N., Cloutier S., Rabzel M., et al. Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta. Pediatrics 2003, 111:e601-e603.
18. Rauch F., Travers R., Munns C., Glorieux F.H. Sclerotic metaphyseal lines in a child treated with pamidronate: histomorphometric analysis. J. Bone Miner. Res. 2004, 19:1191-1193.
19. Rauch F., Cornibert S., Cheung M., Glorieux F.H. Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta. Bone 2007, 40:821-827.
20. Whyte M.P., Wenkert D., Clements K.L., McAlister W.H., Mumm S. Bisphosphonate-induced osteopetrosis. N. Engl. J. Med. 2003, 349:457-463.
21. Marini J.C. Bone: use of bisphosphonates in children-proceed with caution. Nat. Rev., Endocrinol. 2009, 5:241-243.
22. Munns C.F., Rajab M.H., Hong J., Briody J., Hogler W., McQuade M., et al. Acute phase response and mineral status following low dose intravenous zoledronic acid in children. Bone 2007, 41:366-370.
23. Johannesen J., Briody J., McQuade M., Little D.G., Cowell C.T., Munns CF Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease. Bone 2009, 45(5):898-902.
24. Rauch F., Glorieux F.H. Osteogenesis imperfecta. Lancet 2004, 363:1377-1385.
25. Munns C.F., Rauch F., Zeitlin L., Fassier F., Glorieux F.H. Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J. Bone Miner. Res. 2004, 19:1779-1786.
26. Brown J.J., Ramalingam L., Zacharin M.R. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?. Clin. Endocrinol. (Oxf) 2008, 68:863-867.
27. Bachrach L.K., Ward L.M. Clinical review 1: bisphosphonate use in childhood osteoporosis. J. Clin. Endocrinol. Metab. 2009, 94:400-409.
28. Gleeson H., Wiltshire E., Briody J., Hall J., Chaitow J., Sillence D., et al. Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. J. Rheumatol. 2008, 35:707-712.
29. Simm P.J., Allen R.C., Zacharin M.R. Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. J. Pediatr. 2008, 152:571-575.
30. Plotkin H., Rauch F., Zeitlin L., Munns C., Travers R., Glorieux F.H. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J. Clin. Endocrinol. Metab. 2003, 88:4569-4575.
31. Munns C.F., Rauch F., Ward L., Glorieux F.H. Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases. J. Bone Miner. Res. 2004, 19:1742-1745.